Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis

BACKGROUND/AIMS: The objective of this study was to determine the efficacy and safety of add-on therapy with certolizumab pegol (CZP) in active rheumatoid arthritis (RA) patients of a single ethnicity. METHODS: In this 24-week, phase 3, randomized, double-blind, placebo-controlled trial, eligible pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Young Mo, Park, Young-Eun, Park, Won, Choe, Jung-Yoon, Cho, Chul-Soo, Shim, Seung-Cheol, Bae, Sang Cheol, Suh, Chang-Hee, Cha, Hoon-Suk, Koh, Eun Mi, Song, Yeong-Wook, Yoo, Bin, Lee, Shin-Seok, Park, Min-Chan, Lee, Sang-Heon, Arendt, Catherine, Koetse, Willem, Lee, Soo-Kon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234400/
https://www.ncbi.nlm.nih.gov/pubmed/29294598
http://dx.doi.org/10.3904/kjim.2016.213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234400/
https://www.ncbi.nlm.nih.gov/pubmed/29294598
http://dx.doi.org/10.3904/kjim.2016.213

Ejemplares similares